Basit öğe kaydını göster

dc.contributor.authorOzhan, Erdem
dc.contributor.authorKokcu, Arif
dc.contributor.authorYanik, Keramettin
dc.contributor.authorGunaydin, Murat
dc.date.accessioned2020-06-21T13:57:02Z
dc.date.available2020-06-21T13:57:02Z
dc.date.issued2014
dc.identifier.issn0301-2115
dc.identifier.issn1872-7654
dc.identifier.urihttps://doi.org/10.1016/j.ejogrb.2014.04.037
dc.identifier.urihttps://hdl.handle.net/20.500.12712/15107
dc.descriptionWOS: 000339036600024en_US
dc.descriptionPubMed: 24813083en_US
dc.description.abstractObjective: To investigate the diagnostic potentials of the serum levels of nine different biomarkers in endometriosis. Study design: In this case-controlled, prospective clinical study, 80 women underwent laparoscopy or laparotomy with a preliminary diagnosis of chronic pelvic pain, severe secondary dysmenorrhea, infertility, pelvic endometriosis or pelvic mass. The 60 women with confirmed pelvic endometriosis constituted the endometriosis group, and the other 20 women without endometriosis constituted the control group. Preoperative blood samples were obtained for serum biomarker measurements. Serum levels of nine different serum biomarkers including alpha-enolase, macrophage migration inhibitory factor, leptin, interleukin-8, anti-endometrial antibody, phosphoinositide dependent protein kinase 1, CA125, syntaxin-5, and laminin-1 were measured concurrently and compared between the control and endometriosis groups, and among control group and endometriosis subgroups including stage I, stage II, stage III and stage IV endometriosis. Results: The serum levels of alpha-enolase, macrophage migration inhibitory factor, leptin, interleukin-8 and antiendometrial antibodies showed a statistically significant difference neither between control and endometriosis groups nor among control group and endometriosis subgroups. The serum levels of CA125, syntaxin-5 and laminin-1 showed a statistically significant difference both between the control and endometriosis groups (p < 0.01) and among control group and endometriosis subgroups (p < 0.01). Serum levels of laminin-1 in stage II and IV endometriosis; syntaxin-5 in stage I and II endometriosis; and CA125 in stage III and IV endometriosis were found to have the different levels compared to control group. Conclusions: These findings show that the concurrent measurement of CA125, syntaxin-5 and laminin-1 might be a useful non-invasive test in strengthening the diagnosis of endometriosis and in predicting its severity. (C) 2014 Elsevier Ireland Ltd. All rights reserved.en_US
dc.description.sponsorshipUniversity of Ondokuz MayisOndokuz Mayis University [PYO.TIP.1904.12.038]en_US
dc.description.sponsorshipThis study was supported by the scientific research funding of the University of Ondokuz Mayis with the project number PYO.TIP.1904.12.038.en_US
dc.language.isoengen_US
dc.publisherElsevier Science Bven_US
dc.relation.isversionof10.1016/j.ejogrb.2014.04.037en_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectEndometriosisen_US
dc.subjectSerum biomarkersen_US
dc.subjectCA125en_US
dc.subjectSyntaxin-5en_US
dc.subjectLaminin-1en_US
dc.titleInvestigation of diagnostic potentials of nine different biomarkers in endometriosisen_US
dc.typearticleen_US
dc.contributor.departmentOMÜen_US
dc.identifier.volume178en_US
dc.identifier.startpage128en_US
dc.identifier.endpage133en_US
dc.relation.journalEuropean Journal of Obstetrics & Gynecology and Reproductive Biologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster